Genitourinary rhabdomyosarcoma: Treatment options

Urologic Clinics of North America

Volumn 27, Issue 3, 2000, Pages 471-487

  Kaefer, Martin ^a   Rink, Richard C ^a  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; HUMAN; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; TUMOR CLASSIFICATION; URINE RETENTION; UROGENITAL TRACT TUMOR;

EID: 0033849172     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70095-1     Document Type: Article

References (98)

1. Progress in the surgical management of vaginal rhabdomyosarcoma: A 25- year review from the Intergroup Rhabdomyosarcoma Study Group
2. Conservative surgery in multimodal therapy for pelvic rhabdomyosarcoma in children
3. Ultrasonography and diagnosis of pediatric genitourinary rhabdomyosarcoma
4. Rearrangement of the PAX3 paired box gene in the paediatric solid tumor alveolar rhabdomyosarcoma
5. Rhabdomyosarcoma mimicking Wilms' tumor
6. Paratesticular rhabdomyosarcoma: Results of therapy in 18 cases
7. Pelvic rhabdomyosarcoma in children
8. Pure embryonal rhabdomyosarcoma of the fallopian tube
9. Spindle cell rhabdomyosarcoma: A prognostically favorable variant of rhabdomyosarcoma
10. Primary embryonal rhabdomyosarcoma of the ovary in a 4-year-old girl
11. Immunohistochemical detection of P-glycoprotein: Prognostic correlation of soft tissue sarcoma of childhood
12. Prognosis in children with rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Studies I and II
13. Therapy associated differentiation in rhabdomyosarcomas
14. Potentiation of x-ray effects by actinomycin D
15. Expression of a single transfected cDNA converts fibroblasts to myoblasts
16. Multiple primary neoplasms in patients with testicular germ cell tumor
17. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma
18. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation
19. MYCN gene amplification in rhabdomyosarcoma
20. Reconstructive options in genitourinary rhabdomyosarcoma
21. A long-term follow-up of the colonic conduit operation in children
22. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma
23. The management of paratesticular rhabdomyosarcoma: A single institutional experience with 44 consecutive children
24. Magnetic resonance imaging for diagnosis and follow-up of genitourinary, pelvic, and perineal rhabdomyosarcoma
25. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors
26. N-myc oncogene amplification in rhabdomyosarcoma at relapse
27. The role of retroperitoneal lymphadenectomy in localized paratesticular rhabdomyosarcoma
28. Leiomyosarcoma and rhabdomyosarcoma: Rare tumors of the kidney
29. Primary rhabdomyosarcoma of the kidney: A light microscopic, immunohistochemical, and electron microscopic study
30. Pelvic rhabdomyosarcoma in infants and children
31. Rhabdomyosarcoma in childhood: Analysis of survival in 98 cases
32. Subsequent urethral relapses with extension into the corpora cavernosa of embryonal rhabdomyosarcoma of the prostate
33. Bladder/prostate rhabdomyosarcoma: Results of the multi-institutional trials of the Intergroup Rhabdomyosarcoma Study
34. New approaches to the surgical management of rhabdomyosarcoma in childhood
35. Pelvic rhabdomyosarcoma in childhood: Diagnosis and concepts of management reviewed
36. Partial cystectomy in the management of rhabdomyosarcoma of the bladder: A report from the Intergroup Rhabdomyosarcoma Study
37. Bladder and prostatic tumors in the Intergroup Rhabdomyosarcoma Study (IRS-I): Results of therapy
38. Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents
39. Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarcoma?
40. The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children
41. Preservation of the bladder in patients with rhabdomyosarcoma
42. Late effects of therapy in patients with paratesticular rhabdomyosarcoma: Intergroup Rhabdomyosarcoma Study Committee
43. Bladder management in children with genitourinary sarcoma
44. Rhabdomyosarcoma: A clinicopathological study and classification of 39 cases
45. Scheduling of vincristine: Drug accumulation and response of xenografts of childhood rhabdomyosarcoma determined by frequency of administration
46. Paratesticular rhabdomyosarcoma: Delayed effects of multimodality therapy and implications for current management
47. Testicular function following combination chemotherapy with cisplatin, vinblastine, and bleomycin
48. Rhabdomyosarcoma of the ovary with late involvement of the central nervous system
49. Pediatric urologic oncology
50. Advances in the treatment of rhabdomyosarcoma
51. The use of continent diversion in the management of rhabdomyosarcoma of the prostate in childhood
52. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region: A report of the Intergroup Rhabdomyosarcoma Study
53. Soft tissue sarcomas, breast cancer, and other neoplasms: A familial syndrome
54. Genito-urinary rhabdomyosarcoma in children
55. The Intergroup Rhabdomyosarcoma Study-I: A final report
56. The Intergroup Rhabdomyosarcoma Study: A preliminary report
57. Rhabdomyosarcoma complicating multiple neurofibromatosis
58. Outcome analysis of rhabdomyosarcoma of the lower urinary tract
59. Classification of rhabdomyosarcomas and related sarcomas
60. Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo
61. Primary ovarian rhabdomyosarcoma: A report of 13 cases
62. Paraaortic lymphadenectomy is not necessary in the treatment of localized paratesticular rhabdomyosarcoma
63. The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: A review
64. Rhabdomyosarcoma: Clinical and pathological features and comparison with human fetal and embryonal skeletal muscle
65. Rhabdomyosarcoma in children
66. Solid tumors of childhood
67. Primary site as a prognostic variable for children with pelvic soft tissue sarcomas
68. Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response
69. Primary chemotherapy with or without radiation therapy and/ or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus and cervix: A comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II
70. Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate: A report from the Intergroup Rhabdomyosarcoma Study Committee
71. Paratesticular sarcoma in childhood and adolescence: A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1973-1983
72. Application of an anti-myosin antibody for scintigraphic differential diagnosis of infantile tumors
73. Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: A report from the International Rhabdomyosarcoma Workshop
74. Indications for hemiscrotectomy in the management of genitourinary tumors in children
75. Congenital anomalies associated with rhabdomyosarcoma: An autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee
76. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma
77. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping
78. Molecular differential pathology of rhabdomyosarcoma
79. Fate of 90 children with ileal conduit urinary diversion a decade later: Analysis of complications, pyelography renal function and bacteriology
80. Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma
81. Genitourinary rhabdomyosarcoma in childhood: Current treatment alternatives and controversies in management
82. Pediatric genitourinary rhabdomyosarcom
83. Pediatric oncology
84. Embryonal rhabdomyosarcoma of the head and neck in children and adolescents
85. Prognosis in childhood rhabdomyosarcoma
86. Radiation of rhabdomyosarcoma in children: Local control in patients enrolled into the Intergroup Rhabdomyosarcoma Study
87. Transrectal ultrasound in the evaluation of rhabdomyosarcoma involving the prostate
88. Changes in early and late radiation reponses with altered dose fractionation: Implications for dose-survival relationships
89. Consistent chromosomal translocation in alveolar rhabdomyosarcoma
90. Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations
91. Chromosomal analysis of sixteen human rhabdomyosarcomas
92. Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma
93. Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas
94. Immunohistology, cytogenetics and molecular studies of small round cell tumors of childhood
95. Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood
96. Incidence of malignant tumors in U.S. children
97. Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals